BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12752399)

  • 1. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
    Debruyne JC; Versijpt J; Van Laere KJ; De Vos F; Keppens J; Strijckmans K; Achten E; Slegers G; Dierckx RA; Korf J; De Reuck JL
    Eur J Neurol; 2003 May; 10(3):257-64. PubMed ID: 12752399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.
    Banati RB; Newcombe J; Gunn RN; Cagnin A; Turkheimer F; Heppner F; Price G; Wegner F; Giovannoni G; Miller DH; Perkin GD; Smith T; Hewson AK; Bydder G; Kreutzberg GW; Jones T; Cuzner ML; Myers R
    Brain; 2000 Nov; 123 ( Pt 11)():2321-37. PubMed ID: 11050032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
    Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
    J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study.
    Versijpt J; Debruyne JC; Van Laere KJ; De Vos F; Keppens J; Strijckmans K; Achten E; Slegers G; Dierckx RA; Korf J; De Reuck JL
    Mult Scler; 2005 Apr; 11(2):127-34. PubMed ID: 15794383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vowinckel E; Reutens D; Becher B; Verge G; Evans A; Owens T; Antel JP
    J Neurosci Res; 1997 Oct; 50(2):345-53. PubMed ID: 9373043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients.
    Debruyne JC; Van Laere KJ; Versijpt J; De Vos F; Eng JK; Strijckmans K; Santens P; Achten E; Slegers G; Korf J; Dierckx RA; De Reuck JL
    Acta Neurol Belg; 2002 Sep; 102(3):127-35. PubMed ID: 12400251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
    Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Sucksdorff M; Matilainen M; Tuisku J; Polvinen E; Vuorimaa A; Rokka J; Nylund M; Rissanen E; Airas L
    Brain; 2020 Dec; 143(11):3318-3330. PubMed ID: 33006604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.
    Kaunzner UW; Kang Y; Monohan E; Kothari PJ; Nealon N; Perumal J; Vartanian T; Kuceyeski A; Vallabhajosula S; Mozley PD; Riley CS; Newman SM; Gauthier SA
    Mult Scler Relat Disord; 2017 Jul; 15():27-33. PubMed ID: 28641769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
    Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
    J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
    Kaunzner UW; Kang Y; Zhang S; Morris E; Yao Y; Pandya S; Hurtado Rua SM; Park C; Gillen KM; Nguyen TD; Wang Y; Pitt D; Gauthier SA
    Brain; 2019 Jan; 142(1):133-145. PubMed ID: 30561514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis.
    Banati RB; Goerres GW; Myers R; Gunn RN; Turkheimer FE; Kreutzberg GW; Brooks DJ; Jones T; Duncan JS
    Neurology; 1999 Dec; 53(9):2199-203. PubMed ID: 10599809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas.
    Takaya S; Hashikawa K; Turkheimer FE; Mottram N; Deprez M; Ishizu K; Kawashima H; Akiyama H; Fukuyama H; Banati RB; Roncaroli F
    J Neurooncol; 2007 Oct; 85(1):95-103. PubMed ID: 17520179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two activated stages of microglia and PET imaging of peripheral benzodiazepine receptors with [(11)C]PK11195 in rats.
    Ito F; Toyama H; Kudo G; Suzuki H; Hatano K; Ichise M; Katada K; Ito K; Sawada M
    Ann Nucl Med; 2010 Apr; 24(3):163-9. PubMed ID: 20101481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
    Vas A; Shchukin Y; Karrenbauer VD; Cselényi Z; Kostulas K; Hillert J; Savic I; Takano A; Halldin C; Gulyás B
    J Neurol Sci; 2008 Jan; 264(1-2):9-17. PubMed ID: 17727889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors.
    Boutin H; Chauveau F; Thominiaux C; Kuhnast B; Grégoire MC; Jan S; Trebossen R; Dollé F; Tavitian B; Mattner F; Katsifis A
    Glia; 2007 Nov; 55(14):1459-68. PubMed ID: 17680643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure.
    Kannan S; Saadani-Makki F; Balakrishnan B; Chakraborty P; Janisse J; Lu X; Muzik O; Romero R; Chugani DC
    Dev Neurosci; 2011; 33(3-4):231-40. PubMed ID: 21791891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
    Politis M; Giannetti P; Su P; Turkheimer F; Keihaninejad S; Wu K; Waldman A; Malik O; Matthews PM; Reynolds R; Nicholas R; Piccini P
    Neurology; 2012 Aug; 79(6):523-30. PubMed ID: 22764258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET.
    Kannan S; Saadani-Makki F; Muzik O; Chakraborty P; Mangner TJ; Janisse J; Romero R; Chugani DC
    J Nucl Med; 2007 Jun; 48(6):946-54. PubMed ID: 17504871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.
    Venneti S; Lopresti BJ; Wang G; Slagel SL; Mason NS; Mathis CA; Fischer ML; Larsen NJ; Mortimer AD; Hastings TG; Smith AD; Zigmond MJ; Suhara T; Higuchi M; Wiley CA
    J Neurochem; 2007 Sep; 102(6):2118-2131. PubMed ID: 17555551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.